Sign Out
Eculizumab is a humanised monoclonal (IgG2/4κ) antibody produced in NS0 cell line by recombinant DNA technology.
One vial of 30 ml contains 300 mg of eculizumab (10 mg/ml).
After dilution, the final concentration of the solution to be infused is 5 mg/ml.
Excipients with known effect: Sodium (5mmol per vial).
Excipients/Inactive Ingredients: Monobasic sodium phosphate, Dibasic sodium phosphate, Sodium chloride, Polysorbate 80, Water for injections.
